SDC4 and glioblastoma: Interestingly, syndecan-4 mRNA expression has been indicated as a novel marker for the prediction of glioblastoma multiforme patients’ response to treatment with the WT1 peptide vaccine [74], and its expression is altered in pediatric astrocytoma [75].